Tag: Telaglenastat

Glutaminase inhibitor telaglenastat does not improve survival mRCC

Presented By
Dr Nizar Tannir, Houston University, TX, USA
Trial
Phase 3, CANTATA
Conference
ASCO 2021
Type
Peer-reviewed article

12 August 2021 20:26
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com